Pneumocystis jirovecii infection: Cell wall (1→3)-β-D-glucan biology and diagnostic utility

References

• Aliouat EM, Pottier M, Gantois N, Dei-Cas E. (2009). The Pneumocystis life cycle. Mem Inst Oswaldo Cruz 104, 419–426.
   PubMedGoogle Scholar
• Azoulay E, Bergeron A, Chevret S, Bele N, Schlemmer B, Menotti J. (2009). Polymerase chain reaction for diagnosing Pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates. Chest 135, 655–651.
   PubMed Web of Science ®Google Scholar
• Beard CR, Carter JL, Keely SP, Huang L, Pieniazek NJ, Moura INS, Roberts JM, Hightower AW, Bens MS, Freeman AR, Lee S, Stringer JR, Duchin JS, del Rio C, RimLand D, Baughman RP, Levy D, Dietz VJ, Simon P, Navin TR. (2000). Genetic variation in Pneumocystis carinii isolates from different geographic regions, Implications for transmission. Emerg Infect Dis 6, 265–272.
   PubMed Web of Science ®Google Scholar
• Beck JM, Cushion MT. (2009). Pneumocystis Workshop, 10th anniversary summary. Euk Cell 8, 446–460.
   PubMed Web of Science ®Google Scholar
• Bowers GJ, Patchen ML, MacVittie TJ, Hirsch EF, Fink MP. (1986). A comparative evaluation of particulate and soluble glucan in an endotoxin model. Int Soc Immunopharm 8, 313–321.
   PubMed Web of Science ®Google Scholar
• Bryar JM, Hammond SP, Tolaney SM, Marty FM, Baden LR. (2009). Pneumocystis jirovecii pneumonia. (PCP). in patients with early stage (ES) breast cancer (BC). Poster K-950, Inter-Science Conference on Antimicrobial Agents and Chemotherapy, San Francisco.
   Google Scholar
• Calderon EJ, Rivero L, Respaldiza N, Morilla R, Montes-Cano MA, Friaza V, Munoz-Lobato F, Varela JM, Medrano FJ, de la Horra C. (2007). Systemic inflammation in patients with chronic obstructive pulmonary disease who are colonized with Pneumocystis jirovecii. Clin Infect Dis 45, e17–e19.
   PubMed Web of Science ®Google Scholar
• Chagas C. (1909). Nova trypanosomiaze human. Mem Instit Oswaldo Cruz 1, 159–218.
   Google Scholar
• Cook JA, Dougherty WJ, Holt TM. (1980). Enhanced sensitivity to endotoxin induced by the RE stimulant, glucan. Circulatory Shock 7, 225–238.
   PubMedGoogle Scholar
• Cordani S, Annunziata M, Vignali M, Tascini C. (2008). Bronchoalveolar lavage as a diagnostic tool in patients with hematological malignancies and pneumonia. Le Infezione in Medicina 4, 209–213.
   Google Scholar
• Crothers K, Huang L. (2009). Pulmonary complications of immune reconstitution inflammatory syndromes in HIV-infected patients. Respirology 14, 486–494.
   PubMedGoogle Scholar
• Cuetara MS, Alhambra A, Chaves F, Moragues MD, Ponton J, del Palacio A. (2008). Use of a serum. (1→3).-β-D-glucan assay for diagnosis and follow-up of Pneumocystis jirovecii pneumonia. Clin Infect Dis 47, 1364–1366.
   PubMedGoogle Scholar
• Cushion MT, Waltzer PD, Smulian AG, Linke MJ, Ruffolo JJ, Kaneshiro ES, Stringer JR. (1997). Terminology for the life cycle of Pneumocystis carinii. Infect Immun 65, 4365.
   PubMedGoogle Scholar
• Davis JL, Welsh DA, Beard CB, Jones JL, Lawrence GG, Fox MR, Crothers K, Morris A, Charbonnet D, Swartzman A, Huang L. (2008). Pneumocystis colonization is common among hospitalized HIV patients with non-Pneumocystis infection. Thorax 63, 329–334.
   PubMed Web of Science ®Google Scholar
• De Souza W, Benchimol M. (2005). Basic biology of Pneumocystis carinii – A mini review. Mem Inst Oswaldo Cruz 100, 903–908.
   PubMed Web of Science ®Google Scholar
• Del Bono V, Mularoni A, Furfaro E, Delfino E, Rosasco L, Miletich F, Viscoli C. (2009). Clinical evaluation of. (1,3).-β-d-glucan assay in presumptive Pneumocystis jirovecii pneumonia in immunocompromised patients. Clin Vacc Immunol 16, 1524–1526.
   PubMed Web of Science ®Google Scholar
• Delanoe P, Delanoe M. (1912). Sur les rapports des kystes de Carinii du poumon des rats avec le trypanosome. Lewisii CR Acad Sci (Paris) 155, 658–570.
   Google Scholar
• Dennehy KM, Ferwerda G, Faro-Trindade I, Pyz E, Willment JA, Taylor PR, Kerrigan A, Tsoni SV, Gordon S, Meyer-Wentrup F, Adema GJ, Kullberg BJ, Schweighoffer E, Tybulewicz V, Mora-Montes HM, Gow NA, Williams DL, Netea MG, Brown GD. (2008). Syk kinase is required for collaborative cytokine production induced through dectin-1 and toll-like receptors. Eur J Immunol 38, 500–506.
   PubMed Web of Science ®Google Scholar
• Dennehy KM, Willment JA, Williams DL, Brown GD. (2009). Reciprocal regulation of IL-23 and IL-12 following co-activation of Dectin-1 and TLR signaling pathways. Eur J Immunol 39, 1379–1386.
   PubMed Web of Science ®Google Scholar
• Desmet S, Van Wijngaerden E, Maertens J, Verhaegen J, Verbeken E, De Munter P, Meersseman W, Van Meense l B, Van Eldere J, Lagrou K. (2009). Serum (1-3)-{beta}-D-Glucan as a Tool for Diagnosis of Pneumocystis jirovecii Pneumonia in Patients with Human Immunodeficiency Virus Infection or Hematological Malignancy. J Clin Microbiol 47, 3781–3784.
   Google Scholar
• Divaret G, Magne D, Angoulvant A, Roux P. (2008). Usefulness of serum (1→3)-β-D-glucan assay for Pneumocystis jirovecii pneumonia diagnosis Abstract P017, International Workshop on Opportunistic Protists, Boston, MA.
   Google Scholar
• Dowdle WR. (1983). The epidemiology of AIDS. Public Health Reports 98, 308–312.
   PubMed Web of Science ®Google Scholar
• Durand-Joly I, Soula F, Dalle JH, Lafitte JJ, Seneschal M, Pinon A, Camus D, Dei-Cas E. (2003). Long-term colonisation with Pneumocystis jirovecii in hospital staffs, a challenge to prevent nosocomial pneumocystosis. J Eukaryot Microbiol 50 Suppl, 614–615.
   PubMedGoogle Scholar
• Ennishi D, Terui Y, Yokoyama M, Mishima Y, Takahashi S, Takeuchi K, Ikeda K, Tanimoto M, Hatake K. (2008). Increased incidence of interstitial pneumonia by CHOP combined with rituximab. Int J Hematol 87, 393–397.
   PubMed Web of Science ®Google Scholar
• Eriksson OE. (1994). Pneumocystis carinii, a parasite in the lungs of mammals, referred to a new family and order (Pneumocystidaceae, Pneumocystidales, Ascomycota). Systema Ascomycetum 13, 165–180.
   Google Scholar
• Finkelman MA, Tamura H. (2007). Detection and measurement of (1→3)-β-D-glucan with Limulus Amebocyte Lysate-based reagents. In “The Toxicology of (1→3)-Beta-Glucans,” ed. SH Young, and V Castranova). Taylor & Francis, Boca Raton.
   Google Scholar
• Gigliotti F, Wright TW. (2005). Immunopathogenesis of Pneumocystis carinii pneumonia. Expert Rev in Molec Med 26, 1–16.
   Google Scholar
• Goodridge HS, Wolf AJ, Underhill DM. (2009). Β-glucan recognition by the innate immune system. Immunol Reviews 230, 38–50.
   PubMed Web of Science ®Google Scholar
• Gutierrez S, Martin-Garrido I, Leon JA, Morilla R, Rivero L, Friza V, Respizalda N, Varela JM, Montes-Cano MA, Medrano JF, de la Horra C, Calderon EJ. (2008). High prevalence of Pneumocystis jirovecii colonization among young HIV-infected patients Abstract P045. International Workshop on Opportunistic Protists Boston, MA.
   Google Scholar
• Gupta D, Zachariah A, Roppelt H, Patel AM, Gruber BL. (2008). Prophylactic antibiotic usage for Pneumocystis jirovecii pneumonia in patients with systemic lupus erythematosus on cyclophosphamide, a survey of US rheumatologists and review of the literature. J Clin Rheumatol 14, 267–272.
   PubMed Web of Science ®Google Scholar
• Hahn PY, Evans SE, Kottom TJ, Standing JE, Pagano RE, Limper AH. (2003). Pneumocystis carinii wall β-glucan induces release of macrophage inflammatory protein-2 from alveolar epithelia cells via lactosylceramide-mediated mechanism. J Biol Chem 278, 2043–2050.
   PubMedGoogle Scholar
• Hazam S, Watanabe S, Ohashi M, Yagi M, Suzuki M, Matsuda K, Yamamoto T, Suga Y, Suga T, nakazawa S, Oka M. (2009). Efficacy of orally administered superfine dispersed lentinan. (1→3).-β—glucan) for the treatment of advanced colorectal cancer. Anticancer Res 29, 2611–2617.
   PubMed Web of Science ®Google Scholar
• Hong F, Hansen RD, Yan J, Allendorf DJ, Baran J, Ostroff GR, Ross GD. (2003). Β-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells (2003). Cancer Res 63, 9023–9031.
   PubMed Web of Science ®Google Scholar
• Hong F, Yan J, Baran JT, Allendorf DJ, Hansen RD, Ostroff GR, Xing PX, Cheung NKV, Ross GD. (2004). Mechanism by which orally administered β-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J Immunol 173, 797–806.
   PubMed Web of Science ®Google Scholar
• Huang L, Morris A, Limper AH, Beck JM; ATS Pneumocystis Workshop Participants. (2006). An official ATS workshop summary, Recent advances and future directions in Pneumocystis pneumonia. Proc Am Thorac Soc 3, 655–664.
   PubMedGoogle Scholar
• Iwanaga S. (1993). The Limulus clotting reaction. Curr Opin Immunol 5, 74–82.
   PubMed Web of Science ®Google Scholar
• Jiancheng W, Minjun H, Yi-jun A, Lan S, Zengzhu G, Jianrong SS, Xixiong K. (2009). Screening Pneumocystis carinii pneumonia in non-HIV-infected immunocompromised patients using polymerase chain reaction. Diagn Microbiol Infect Dis 64, 396–401.
   PubMedGoogle Scholar
• Kampf G, Assmann N, Ruden H. (1998). Direct detection of Pneumocystis carinii in outdoor air, Preliminary results of a field study. Zentralbl Hyg Umweltmed 201, 241–249.
   PubMedGoogle Scholar
• Kaur N, Mahl TC. (2008). Pneumocystis jirovecii. (carinii). pneumonia after infliximab therapy, A review of 84 cases. Dig Dis Sci 52, 1481–1484.
   Google Scholar
• Keely SP, Stringer JR. (1996). Multi-locus genotype switching in Pneumocystis carinii sp F hominis, Evidence for reinfection. J Euk Microbiol 43, 50S.
   Google Scholar
• Kelley CF, Checkley W, Mannino DM, Franco-Paredes C, Del Rio C, Holguin F. (2009). Trends in hospitalization for AIDS-associated Pneumocystis jirovecii pneumonia in the United States (1986-2005). Chest 136, 190–197.
   PubMedGoogle Scholar
• Kerrigan AM, Brown GD. (2009). C-Type lectins and phagocytosis. Immunobiology 214, 562–575.
   PubMed Web of Science ®Google Scholar
• Kikkert R, Bulder I, de Groot ER, Aarden LA, Finkelman MA. (2007). Potentiation of toll-like receptor-induced cytokine production by (1→3)-β-D-glucans, implications for the monocyte activation test. J Endotoxin Res 13, 140–149.
   PubMedGoogle Scholar
• Koike R, Takeuchi T, Eguchi K, Miyasaka N. (2007). Update on the Japanese guidelines for the use of infliximab and eternacept in rheumatoid arthritis. Mod Rheumatol 17, 451–458.
   PubMedGoogle Scholar
• Kolstad A, Holte H, Fossa A, Lauritzsen G, Gaustad P, Torfoss D. (2007). Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen. Haematologica 92, 139–140.
   PubMed Web of Science ®Google Scholar
• Koo S, Bryar JM, Page JH, Baden LR, Marty FM. (2009). Diagnostic performance of the (1—>3)-beta-D-glucan assay for invasive fungal disease. Clin Inf Dis 49, 1650–1659.
   PubMed Web of Science ®Google Scholar
• Kottom TJ, Limper, AH. (2000). Cell wall assembly by Pneumocystis carinii, Evidence for a unique Gsc-1 subunit mediating β-1,3-glucan deposition. J Biol Chem 275, 40628–40634.
   PubMed Web of Science ®Google Scholar
• Kovacs JA, Masur H. (2009). Evolving health effects of Pneumocystis, One hundred years of progress in diagnosis and treatment. JAMA 301, 2578–2585.
   PubMed Web of Science ®Google Scholar
• Kuehnhardt D, Hannemann M, Schmidt B, Heider U, Possinger K, Eucker J. (2009). Therapeutic implication of BAL in patients with neutropenia. Ann Hematol 88, 1249–1256.
   PubMed Web of Science ®Google Scholar
• Latouche S, Poirot J-L Bernard, C, Roux P. (1997). Study of internal transcribed spacer and mitochondrial large-subunit genes of Pneumocystis carinii hominis isolated by repeated bronchoalveolar lavage from human immunodeficiency virus-infected patients during one or several episodes of pneumonia. J Clin Microbiol 35, 1687–1690.
   PubMed Web of Science ®Google Scholar
• Lautenschlager I, Lyytikainen O, Jokipii L, Jokipii A, Maiche A, Ruutu T, Tukianen P, Ruutu P. (1996). Immunodetection of Pneumocystis carinii in bronchoalveolar lavage specimens compared with methenamine silver stain. J Clin Microbiol 34, 728–730.
   PubMedGoogle Scholar
• Lebron F, Vassallo R, Puri V, Limper AH. (2003). Pneumocystis carinii cell wall β-glucans initiate macrophage inflammatory responses through NF-κB activation. J Biol Chem 278, 25001–25008.
   PubMed Web of Science ®Google Scholar
• Lee JC, Bell DC, Guineness RM, Ahmad T. (2009). Pneumocystis jirovecii pneumonia and pneumomediastinum in an anti-TNFα naïve patient with ulcerative colitis. World J Gastroentol 15, 1897–1900.
   PubMedGoogle Scholar
• Lesage G, Bussey, H. (2006). Cell wall assembly in Saccharomyces cerevisiae. Microbiol Mol Biol Rev 70, 317–343.
   PubMed Web of Science ®Google Scholar
• Levy H. (1994). Comparison of Ballard catheter bronchoalveolar lavage with bronchosopic bronchoalveolar lavage. Chest 106, 1753–1756.
   PubMedGoogle Scholar
• Linssen CFM, Jacobs JA, Beckers P, TemLeton KE, Bakkers J, Huijper EJ, Melchers WJG, Drent M, Vink C. (2006). Inter-laboratory comparison of three different real-time PCR assays for the detection of Pneumocystis jirovecii in bronchoalveolar lavage. J Med Microbiol 55, 1229–1235.
   PubMed Web of Science ®Google Scholar
• Marasca, G and McEvoy, M. (1986). Length of survival of patients with acquired immune deficiency syndrome in the United Kingdom. Brit Med J 292, 1727–1729.
   PubMedGoogle Scholar
• Matsumoto Y, Matsuda S, Tegoshi T. (1989). Yeast glucan in the cyst wall of Pneumocystis carinii. J Protozool 36, 21S–22S.
   PubMedGoogle Scholar
• Matsumoto Y, Yamada M, Amagai T. (1991). Yeast glucan of Pneumocystis carinii cyst wall, an excellent target for chemotherapy. J Protozool 38, 6S–7S.
   Google Scholar
• Medrano FJ, Montes-Cano M, Conde M, de la Horra C, Respaldiza N, Gasch A, Perez-Lozano MJ, Varela JM, Calderon EJ. (2005). Pneumocystis jirovecii in general population. Emerg Infect Dis 11, 245–250.
   PubMed Web of Science ®Google Scholar
• Medrano FJ, Morilla R, Garcia-Fabero N, Respaldiza N, Pinazo S, Friaza V, Cabrera J, de la Horra C, Yang R, Rivero L, Gutierrez S, Martin-Garrido I, Montes-Cano MA, Varela JM, Calderon EJ. (2008). High prevalence of Pneumocystis jirovecii colonization in the general population of southern Spain Abstract P013, International Workshop on Opportunistic Pathogens, Boston, MA.
   Google Scholar
• Mennink-Kersten MASH, Ruegebrink D, Wasei N, Melchers WJG, Verweij PE. (2006). In vitro release by Aspergillus fumigatus of galactofuranose antigens, 1,3-β-D-glucan, and DNA, surrogate markers used for diagnosis of invasive aspergillosis. J Clin Microbiol 44, 1711–1718.
   PubMed Web of Science ®Google Scholar
• Modak S, Hoehne G, Vickers A, O’Reilly RJ, Cheung NKV. (2005). Rituximab therapy of lymphoma is enhanced by orally administered (1→3) (1→4)-β-D-glucan. Leukemia Res 29, 679–683.
   PubMed Web of Science ®Google Scholar
• Monnet X, Vidal-Petiot E, Osman D, Hamzaaoui O, Durrbach A, Goujard C, Miceli C, Bouree P, Richard C. (2008). Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infections. Crit Care 12, R28.
   PubMed Web of Science ®Google Scholar
• Montes-Cano MA, de la Horra C, Dapena FJ, Mateos I, Friaza V, Respaldiza N, Munoz-Lobato F, Medrano FJ, Calderoan EJ, Varela JM. (2007). Dynamic colonization by different Pneumocystis jirovecii genotypes in cystic fibrosis patients. Clin Microbiol Infect 13, 1008–1011.
   PubMed Web of Science ®Google Scholar
• Montes-Cano MA, Chabe M, Fontillon-Alberdi M, de la Horra C, Respaldiza N, Medrano FJ, Varela JM, Dei-Cas E, Calderon EJ. (2009). Vertical transmission of Pneumocystis jirovecii in humans. Emerg Infect Dis 15, 125–127.
   PubMed Web of Science ®Google Scholar
• Moriya K, Miura NN, Adachi Y, Ohno N. (2002). Systemic inflammatory response associated with augmentation and activation of leukocytes in Candida/Indomethacin administered mice. Biol Pharm Bull 25, 816–822.
   PubMed Web of Science ®Google Scholar
• Morris A, Netravali M, Kling HM, Ross T, Sciurba FC, Norris KA. (2008). Relationship of Pneumocystis antibody response to severity of chronic obstructive pulmonary disease. Clin Inf Dis 47, e64–68.
   PubMed Web of Science ®Google Scholar
• Morris A, Sciurba FC, Norris KA. (2008). Pneumocystis, A novel pathogen in chronic obstructive pulmonary disease COPD. J Chronic Obstructive Pulmonary Dis 5, 43–51.
   Web of Science ®Google Scholar
• Morris A, Alexander T, Radhi S, Lucht L, Sciurba FC, Steele C, Norris KA. (2009). Airway obstruction in Pneumocystis-colonized HIV-infected outpatients. J Clin Microbiol 47, 3773–3776.
   PubMed Web of Science ®Google Scholar
• Nakamura H, Tateyama M, Tasato D, Haranaga S, Yara S, Higa F, Ohtsuki Y, Fujita J. (2009). Clinical utility of serum β-D-glucan and KL-6 levels in Pneumocystis jirovecii pneumonia. Intern Med 48, 195–202.
   PubMed Web of Science ®Google Scholar
• Nollstadt KH, Powles MA, Fujioka H, Aikawa M, Schmatz DM. (1994). Use of (1→3)-β-D-glucan-specific antibody to study the cyst wall of Pneumocystis carinii and the effects of pneumocandin B0 analog L-733,560. Antmicrob Agents Chemother 38, 2258–2265.
   PubMed Web of Science ®Google Scholar
• Obayashi T, Negishi K, Suzuki T, Funata N. (2008). Reappraisal of the serum. (1→3).-β-D-glucan assay for the diagnosis of invasive fungal infections-A study based upon autopsy cases from 6 years. Clin Infect Dis 46, 1864–1870.
   PubMed Web of Science ®Google Scholar
• Odabasi Z, Mattiuzzi G, Estey E, Kantarjian H, Saeki F, Ridge R, Ketchum PA, Finkelman MA, Ostrosky-Zeichner L. (2004). Β-D-glucan as a diagnostic adjunct for invasive fungal infections, Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 39, 199–205.
   PubMed Web of Science ®Google Scholar
• Odabasi Z, Paetznick VL, Rodriguez JE, Chen E, McGinnis MR, Ostrosky-Zeichner L. (2005). Differences in beta-glucan levels in culture supernatants of a variety of fungi. Med Mycol 44, 267–272.
   Google Scholar
• Olsson M, Sukura A, Lindberg LA, Linder E. (1996). Detection of Pneumocystis carinii DNA by filtration of air. Scand J Infect Dis 28, 279–282.
   PubMed Web of Science ®Google Scholar
• Olsson M, Lidman C, Latouche S, Bjorckman A, Roux P, Linder E, Wahlgren M. (1998). Identification of Pneumocystis carinii f sp Hominis gene sequences in filtered air in hospital environments. J Clin Micro 36, 1737–1740.
   PubMed Web of Science ®Google Scholar
• Ostrosky-Zeichner L, Alexander BD, Kett DH, Vazquez J, Pappas PG, Saeki F, Ketchum PA, Wingard J, Schiff R, Tamura H, Finkelman MA, Rex JH. (2005). Multicenter clinical evaluation of the (1→3)-β-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 41, 654–659.
   PubMed Web of Science ®Google Scholar
• Pazos C, Ponton J, Del Palacio A. (2005). Contribution of (1→3)-β-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients, A comparison with serial screening for circulating galactomannan. J Clin Microbiol 43, 299–305.
   PubMed Web of Science ®Google Scholar
• Pazos C, Moragues DD, Quindos G, Ponton J, del Palacio A. (2006). Diagnostic potential of (1→3)-β-D-glucan and anti-Candida albicans germ tube antibodies for the diagnosis and therapeutic monitoring of invasive candidiasis in neutropenic adult patients. Rev Iberoam Micol 23, 209–215.
   PubMedGoogle Scholar
• Peglow SL, Smulian AG, Linke MJ, Pogue Cl Nurre, S, Crisler J, Phair J, Gold JW, Armstrong D, Walzer PD. (1990). Serologic responses to Pneumocystis carinii antigens in health and disease. J Infect Dis 161, 296–306.
   PubMed Web of Science ®Google Scholar
• Persat F, Ranque S, Derouin F, Michel-Nguyen A, Picot S, Sulahian A. (2008). Contribution of the (1→3)-β-D-glucan assay for the diagnosis of invasive fungal infection. J Clin Microbiol 46, 1009–1013.
   PubMed Web of Science ®Google Scholar
• Pifer LL, Hughes WT, Stagno S, Woods D. (1978). Pneumocystis carinii infection, evidence for high prevalence in normal and immunosuppressed children. Pediatrics 61, 35–41.
   PubMed Web of Science ®Google Scholar
• Pinlaor S, Mootsikapun P, Pinlaor P, Phunmanee A, Pipitgool V, Sithithaworn P, Chumpia W, Sithithaworn J. (2004). PCR diagnosis of Pneumocystis carinii on sputum and bronchoalveolar lavage samples in immuno-compromised patients. Parasitol Res 94, 213–218.
   PubMed Web of Science ®Google Scholar
• Pisciulli ML, Sax PE. (2008). Use of a serum β-glucan assay for diagnosis of HIV-related Pneumocystis jirovecii pneumonia in patients with negative microscopic examination results. Clin Infect Dis 46, 1928–1930.
   PubMedGoogle Scholar
• Ponce CA, Gallo M, Bustamente R, Vargas SL. (2010). Pneumocystis colonization is highly prevalent in the autopsied lungs of the general population. Clin Inf Dis 50, 347–353.
   PubMed Web of Science ®Google Scholar
• Redhead SA, Cushion MT, Frenkel JK, Stringer JR. (2006). Pneumocystis and Trypanosoma cruzi, Nomenclature and Typifications. J Euk Microbiol 53, 1–10v.
   Google Scholar
• Respalzida N, Medrano FJ, Medrano AC, Varela JM, de la Horra C, Montes-Cano M, Wichman I, Gargallo-Viola D, Calderon EJ. (2004). High seroprevalence of Pneumocystis infection in Spanish children. Clin Microbiol Infect 10, 1029–1031.
   PubMedGoogle Scholar
• Rivero L, de la Horra C, Montes-Cano MA, Rodríguez-Herrera A, Respaldiza N, Friaza V, Morilla R, Gutiérrez S, Varela JM, Medrano FJ, Calderón EJ. (2008). Pneumocystis jirovecii transmission from immunocompetent carriers to infant. Emerg Infect Dis 14, 1116–1118.
   PubMed Web of Science ®Google Scholar
• Rohner P, Jacomo V, Studer R, Schrenzel J, Graf J-D. (2009). Detection of Pneumocystis jirovecii by two staining methods and two quantitative PCR assays. Infection 37, 261–265.
   PubMed Web of Science ®Google Scholar
• Sax P, Komarow L, Finkelman MA, Grant, PM, Andersen, J, Zolopa AR. (2009). (1→3)-β-D-glucan is a promising non-invasive diagnostic test for HIV-related Pneumocystis jirovecii pneumonia Poster H-1564a Inter-Science Conference on Antimicrobial agents and Chemotherapy, San Francisco.
   Google Scholar
• Scheicher ME, Filho JT, Vianna EO. (2003). Sputum induction, review of literature and proposal for a protocol. Sao Paulo Med J 121, 213–219.
   PubMedGoogle Scholar
• Shimizu A, Oka H, Matsuda T, Ozaki S. (2005). (1→3)-β-D-glucan is a diagnostic and negative prognostic marker for Pneumocystis carinii pneumonia in patients with connective tissue disease. Clin Exp Rheum 23, 678–680.
   PubMed Web of Science ®Google Scholar
• Spencer L, Ukwu M, Alexander T, Valadez K, Liu L, Frederick T, Kovacs A, Morris A. (2008). Epidemiology of Pneumocystis colonization in families. Clin Infect Dis 46, 1237–1240.
   PubMedGoogle Scholar
• Stringer JR. (1996). Pneumocystis carinii, What is it exactly? Clin Microbiol Rev 9, 489–498.
   PubMed Web of Science ®Google Scholar
• Takahashi H, Ohno N, Adachi Y, Yadomae T. (2001). Association of immunological disorders in lethal side effect of NSAIDS on β-glucan-administered mice. FEMS 31, 1–14.
   Google Scholar
• Thomas CF, Limper AH. (2004). Pneumocystis pneumonia. NEJM 350, 2487–2498.
   PubMed Web of Science ®Google Scholar
• Tiley SM, Marriott DJ, Harkness JL. (1994). An evaluation of four methods for the detection of Pneumocystis carinii in clinical specimens. Pathology 26, 325–328.
   PubMed Web of Science ®Google Scholar
• Tokuda H, Sakai F, Yamada H, Johkoh T, Imamura A, Dohi M, Hirakata M, Yamada T, Kamatani N, Kikuchi Y, Sugii S, Takeuchi K, Goto H. (2008). Clinical and radiological features of Pneumocystis pneumonia in patients with rheumatoid arthritis, in comparison with methotrexate pneumonitis, and Pneumocystis pneumonia in acquired immunodeficiency syndrome, a multicenter study. Inter Med 47, 915–923.
   PubMed Web of Science ®Google Scholar
• Vassallo R, Standing JE, Limper AH. (2000). Isolated Pneumocystis carinii cell wall glucan provokes lower respiratory tract inflammatory responses. J Immunol 164, 3755–3763.
   PubMed Web of Science ®Google Scholar
• Wakefield AE, Pixley FJ, Banerji S, Sinclair K, Miller RF, Moxon ER, Hopkin JM. (1990). Detection of Pneumocystis carinii with DNA amplification. Lancet 336, 451–453.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Yasuoka A, Tanuma J, Yazaki H, Honda H, Tsukuda H, Honda M, Gatanaga H, Teryua K, Kikuchi Y, Oka S. (2009). Serum (1→3)-β-D-glucan as an adjunct marker for the diagnosis of Pneumocystis pneumonia in patients with AIDS. Clin Inf Dis 49, 1128–1131.
   PubMed Web of Science ®Google Scholar
• Weig M, Klinker H, Wilhelm M, Lemmer K, Gross U. (1996). Correlation of Pneumocystis carinii PCR with clinical diagnosis in immunocompromised patients. Lancet 347, 1266.
   PubMed Web of Science ®Google Scholar
• Werner JL, Metz AE, Horn D, Schoeb TR, Hewitt MM, Schwiebert LM, Faro-Trinidade I, Brown GD, Steele C. (2009). Requisite role for the Dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigates. J Immunol 182, 4938–4946.
   PubMed Web of Science ®Google Scholar
• Williams DL, Lowman DW, Ensley HE. (2007). Introduction to the chemistry and immunobiology of β-glucans. In “The Toxicology of (1→3)-Beta-Glucans,” ed. SH Young, and V Castranova. Taylor & Francis, Boca Raton.
   Google Scholar
• Willment JA, Gordon S, Brown GD. (2001). Characterization of the human beta-glucan receptor and its alternatively spliced forms. J Biol Chem 276, 43, 818–43, 823.
   Google Scholar
• Xia Y, Veticka V, Yan Y, Hanikyrova M, Mayadas T, Ross GD. (1999). The β-glucan-binding lectin site of mouse CR3. (CD11b/CD18). and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. J Immunol 162, 2281–2290.
   PubMed Web of Science ®Google Scholar
• Xia Y, Borland G, Huang J, Mizukami IF, Petty HR, Todd RF, Ross GR. (2002). Function of the lectin domain of Mac-1/complement receptor type 3 (CD11b/CD18) in regulating neutrophil adhesion. J Immunol 169, 6417–6426.
   PubMed Web of Science ®Google Scholar
• Yasuoka A, Tachikawa N, Shimada K, Kimura S, Oka S. (1996). (1→3)-β-D-glucan as a quantitative serological marker for Pneumocystis carinii pneumonia. Clin Diagn Lab Immunol 3, 197–199.
   PubMedGoogle Scholar
• Yazaki Y, Goto N, Uchida K, Kobayashi T, Gatanaga H, Oka Shinichi. (2008). Outbreak of Pneumocystis jirovecii pneumonia is contagious to the susceptible host. Transplantation 88, 380–385.
   Google Scholar